AI English summary of an SEC filing — figures as filed
The company said it will release its fourth-quarter and full-year results for Q4 2023 before the market opens on Thursday, February 15, 2024.
Key points
AI summaryThe company said it will release its fourth-quarter and full-year results for Q4 2023 before the market opens on Thursday, February 15, 2024.
The company said it will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. It said the earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
The company said the webcast and dial-in are listen-only and recommended that participants join 10 minutes before the start. It said a replay will be available approximately 2 hours after the conclusion of the live event, through February 1, 2025.
The company said in its press release that more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022, and performed more than 600 million tests for patients.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Q4 2023 and Full-Year Earnings Release Schedule
The company said it will release its fourth-quarter and full-year results for Q4 2023 before the market opens on Thursday, February 15, 2024.
Source · Based on the filing body and exhibits
Conference Call and Webcast
The company said it will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. It said the earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.
Source · Based on the filing body and exhibits
Participation Method and Replay Availability
The company said the webcast and dial-in are listen-only and recommended that participants join 10 minutes before the start. It said a replay will be available approximately 2 hours after the conclusion of the live event, through February 1, 2025.
Source · Based on the filing body and exhibits
Company Overview Scale Figures
The company said in its press release that more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022, and performed more than 600 million tests for patients.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…